Ortin Laboratories Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹19.72
- Today's High:
- ₹21.5
- Open Price:
- ₹20.7
- 52W Low:
- ₹16.6
- 52W High:
- ₹29.25
- Prev. Close:
- ₹20.75
- Volume:
- 4525
Company Statistics
- Market Cap.:
- ₹524.31 million
- Book Value:
- 13.995
- Revenue TTM:
- ₹2.36 billion
- Operating Margin TTM:
- 1.6%
- Gross Profit TTM:
- ₹427.69 million
- Profit Margin:
- -0.28%
- Return on Assets TTM:
- 2.11%
- Return on Equity TTM:
- 0%
Company Profile
Ortin Laboratories Ltd had its IPO on under the ticker symbol ORTINLAABS.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Ortin Laboratories Ltd has a staff strength of 0 employees.
Stock update
Shares of Ortin Laboratories Ltd opened at ₹20.7 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹19.72 - ₹21.5, and closed at ₹19.72.
This is a -4.96% slip from the previous day's closing price.
A total volume of 4,525 shares were traded at the close of the day’s session.
In the last one week, shares of Ortin Laboratories Ltd have slipped by -4.69%.
Ortin Laboratories Ltd's Key Ratios
Ortin Laboratories Ltd has a market cap of ₹524.31 million, indicating a price to book ratio of 2.0078 and a price to sales ratio of 0.1886.
In the last 12-months Ortin Laboratories Ltd’s revenue was ₹2.36 billion with a gross profit of ₹427.69 million and an EBITDA of ₹57.74 million. The EBITDA ratio measures Ortin Laboratories Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Ortin Laboratories Ltd’s operating margin was 1.6% while its return on assets stood at 2.11% with a return of equity of 0%.
In Q4, Ortin Laboratories Ltd’s quarterly earnings growth was a negative -33.3% while revenue growth was a positive 94%.
Ortin Laboratories Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-0.38 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ortin Laboratories Ltd’s profitability.
Ortin Laboratories Ltd stock is trading at a EV to sales ratio of 0.2841 and a EV to EBITDA ratio of 6.3485. Its price to sales ratio in the trailing 12-months stood at 0.1886.
Ortin Laboratories Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.26 billion
- Total Liabilities
- ₹893.15 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Ortin Laboratories Ltd ended 2024 with ₹1.26 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.26 billion while shareholder equity stood at ₹261.13 million.
Ortin Laboratories Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹893.15 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹13.02 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹58.18 million.
Ortin Laboratories Ltd’s total current assets stands at ₹1.02 billion while long-term investments were ₹0 and short-term investments were ₹18.59 million. Its net receivables were ₹605.04 million compared to accounts payable of ₹616.38 million and inventory worth ₹377.90 million.
In 2024, Ortin Laboratories Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Ortin Laboratories Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹19.72
- 52-Week High
- ₹29.25
- 52-Week Low
- ₹16.6
- Analyst Target Price
- ₹
Ortin Laboratories Ltd stock is currently trading at ₹19.72 per share. It touched a 52-week high of ₹29.25 and a 52-week low of ₹29.25. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹20.19 and 200-day moving average was ₹21.48 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 3745.4% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Ortin Laboratories Ltd
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Ortin Laboratories Limited manufactures and sells pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company’s formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro virals, anti diabetics, analgesics and antipyretics, anti biotics, antifungals, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was founded in 1986 and is based in Hyderabad, India.